179 related articles for article (PubMed ID: 31905374)
1. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
[TBL] [Abstract][Full Text] [Related]
2. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
3. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis.
Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST
mBio; 2018 Oct; 9(5):. PubMed ID: 30301850
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
9. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis.
Lu X; Tang J; Liu Z; Li M; Zhang T; Zhang X; Ding K
Bioorg Med Chem Lett; 2016 Dec; 26(24):5916-5919. PubMed ID: 27839917
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
[TBL] [Abstract][Full Text] [Related]
12. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of an imidazo[1, 2-a]pyridine using a mouse M. tuberculosis infection model.
Cheng Y; Moraski GC; Cramer J; Miller MJ; Schorey JS
PLoS One; 2014; 9(1):e87483. PubMed ID: 24498115
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M
Eur J Med Chem; 2001 Sep; 36(9):743-6. PubMed ID: 11672884
[TBL] [Abstract][Full Text] [Related]
15. 6-Oxo and 6-thio purine analogs as antimycobacterial agents.
Pathak AK; Pathak V; Seitz LE; Suling WJ; Reynolds RC
Bioorg Med Chem; 2013 Apr; 21(7):1685-95. PubMed ID: 23434367
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB.
Abrahams KA; Cox JA; Spivey VL; Loman NJ; Pallen MJ; Constantinidou C; Fernández R; Alemparte C; Remuiñán MJ; Barros D; Ballell L; Besra GS
PLoS One; 2012; 7(12):e52951. PubMed ID: 23300833
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
[TBL] [Abstract][Full Text] [Related]
20. Click synthesis of 1,2,3-triazole based imidazoles: Antitubercular evaluation, molecular docking and HSA binding studies.
Pradeep Kumar CB; Prathibha BS; Prasad KNN; Raghu MS; Prashanth MK; Jayanna BK; Alharthi FA; Chandrasekhar S; Revanasiddappa HD; Yogesh Kumar K
Bioorg Med Chem Lett; 2021 Mar; 36():127810. PubMed ID: 33482292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
